XML 196 R123.htm IDEA: XBRL DOCUMENT v3.22.4
Non-current financial debt (Details 1)
€ in Millions, SFr in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2022
CHF (SFr)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
Disclosure of detailed information about borrowings [line items]          
Straight bonds $ 22,341     $ 25,296  
2.4% USD 1 500 million bond 2012/2022 of Novartis Capital Corporation, New York United States, issued at 99.225% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 2.40% 2.40% 2.40%    
Borrowings, original currency USD        
Notional amount $ 1,500        
Borrowings, issuance year 2012        
Borrowings, maturity year 2022        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.225%        
Straight bonds       1,498  
3.7% USD 500 million bond 2012/2042 of Novartis Capital Corporation, New York United States, issued at 98.325% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 3.70% 3.70% 3.70%    
Borrowings, original currency USD        
Notional amount $ 500        
Borrowings, issuance year 2012        
Borrowings, maturity year 2042        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 98.325%        
Straight bonds $ 490     490  
3.4% USD 2 150 million bond 2014/2024 of Novartis Capital Corporation, New York United States, issued at 99.287% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 3.40% 3.40% 3.40%    
Borrowings, original currency USD        
Notional amount $ 2,150        
Borrowings, issuance year 2014        
Borrowings, maturity year 2024        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.287%        
Straight bonds $ 2,147     2,144  
4.4% USD 1 850 million bond 2014/2044 of Novartis Capital Corporation, New York United States, issued at 99.196% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 4.40% 4.40% 4.40%    
Borrowings, original currency USD        
Notional amount $ 1,850        
Borrowings, issuance year 2014        
Borrowings, maturity year 2044        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.196%        
Straight bonds $ 1,827     1,826  
1.625% EUR 600 million bond 2014/2026 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.697% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 1.625% 1.625% 1.625%    
Borrowings, original currency EUR        
Notional amount | €   € 600      
Borrowings, issuance year 2014        
Borrowings, maturity year 2026        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 99.697%        
Straight bonds $ 638     676  
0.25% CHF 500 million bond 2015/2025 of Novartis AG Basel Switzerland, issued at 100.64% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 0.25% 0.25% 0.25%    
Borrowings, original currency CHF        
Notional amount | SFr     SFr 500    
Borrowings, issuance year 2015        
Borrowings, maturity year 2025        
Borrowings, issuer Novartis AG, Basel, Switzerland        
Borrowings, issue price 100.64%        
Straight bonds $ 541     547  
0.625% CHF 550 million bond 2015/2029 of Novartis AG Basel Switzerland, issued at 100.502% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 0.625% 0.625% 0.625%    
Borrowings, original currency CHF        
Notional amount | SFr     SFr 550    
Borrowings, issuance year 2015        
Borrowings, maturity year 2029        
Borrowings, issuer Novartis AG, Basel, Switzerland        
Borrowings, issue price 100.502%        
Straight bonds $ 595     602  
1.050% CHF 325 million bond 2015/2035 of Novartis AG Basel Switzerland, issued at 100.479% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 1.05% 1.05% 1.05%    
Borrowings, original currency CHF        
Notional amount | SFr     SFr 325    
Borrowings, issuance year 2015        
Borrowings, maturity year 2035        
Borrowings, issuer Novartis AG, Basel, Switzerland        
Borrowings, issue price 100.479%        
Straight bonds $ 352     356  
3.0% USD 1 750 million bond 2015/2025 of Novartis Capital Corporation, New York United States, issued at 99.010% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 3.00% 3.00% 3.00%    
Borrowings, original currency USD        
Notional amount $ 1,750        
Borrowings, issuance year 2015        
Borrowings, maturity year 2025        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.01%        
Straight bonds $ 1,742     1,740  
4.0% USD 1 250 million bond 2015/2045 of Novartis Capital Corporation, New York United States, issued at 98.029% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 4.00% 4.00% 4.00%    
Borrowings, original currency USD        
Notional amount $ 1,250        
Borrowings, issuance year 2015        
Borrowings, maturity year 2045        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 98.029%        
Straight bonds $ 1,221     1,220  
0.125% EUR 1 250 million bond 2016/2023 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.127% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 0.125% 0.125% 0.125%    
Borrowings, original currency EUR        
Notional amount | €   € 1,250      
Borrowings, issuance year 2016        
Borrowings, maturity year 2023        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 99.127%        
Straight bonds $ 1,330     1,409  
0.625% EUR 500 million bond 2016/2028 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 98.48% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 0.625% 0.625% 0.625%    
Borrowings, original currency EUR        
Notional amount | €   € 500      
Borrowings, issuance year 2016        
Borrowings, maturity year 2028        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 98.48%        
Straight bonds $ 528     559  
2.400% USD 1'000 million 2017/2022 of Novartis Capital Corporation, New York, United States, issued at 99.449% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 2.40% 2.40% 2.40%    
Borrowings, original currency USD        
Notional amount $ 1,000        
Borrowings, issuance year 2017        
Borrowings, maturity year 2022        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.449%        
Straight bonds       1,000  
3.100% USD 1'000 million 2017/2027 of Novartis Capital Corporation, New York, United States, issued at 99.109% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 3.10% 3.10% 3.10%    
Borrowings, original currency USD        
Notional amount $ 1,000        
Borrowings, issuance year 2017        
Borrowings, maturity year 2027        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.109%        
Straight bonds $ 994     993  
1.125% EUR 600 million 2017/2027 of Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.874% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 1.125% 1.125% 1.125%    
Borrowings, original currency EUR        
Notional amount | €   € 600      
Borrowings, issuance year 2017        
Borrowings, maturity year 2027        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 99.874%        
Straight bonds $ 638     677  
0.500% EUR 750 million 2018/2023 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.655% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 0.50% 0.50% 0.50%    
Borrowings, original currency EUR        
Notional amount | €   € 750      
Borrowings, issuance year 2018        
Borrowings, maturity year 2023        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 99.655%        
Straight bonds $ 798     846  
1.375% EUR 750 million 2018/2030 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.957% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 1.375% 1.375% 1.375%    
Borrowings, original currency EUR        
Notional amount | €   € 750      
Borrowings, issuance year 2018        
Borrowings, maturity year 2030        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 99.957%        
Straight bonds $ 797     846  
1.700% EUR 750 million 2018/2038 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.217% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 1.70% 1.70% 1.70%    
Borrowings, original currency EUR        
Notional amount | €   € 750      
Borrowings, issuance year 2018        
Borrowings, maturity year 2038        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 99.217%        
Straight bonds $ 792     840  
1.750% USD 1 000 million 2020/2025 Novartis Capital Corporation, New York, United States, issued at 99.852% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 1.75% 1.75% 1.75%    
Borrowings, original currency USD        
Notional amount $ 1,000        
Borrowings, issuance year 2020        
Borrowings, maturity year 2025        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.852%        
Straight bonds $ 998     998  
2.000% USD 1 250 million 2020/2027 Novartis Capital Corporation, New York, United States, issued at 99.909% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 2.00% 2.00% 2.00%    
Borrowings, original currency USD        
Notional amount $ 1,250        
Borrowings, issuance year 2020        
Borrowings, maturity year 2027        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.909%        
Straight bonds $ 1,246     1,246  
2.200% USD 1 500 million 2020/2030 Novartis Capital Corporation, New York, United States, issued at 99.869% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 2.20% 2.20% 2.20%    
Borrowings, original currency USD        
Notional amount $ 1,500        
Borrowings, issuance year 2020        
Borrowings, maturity year 2030        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 99.869%        
Straight bonds $ 1,494     1,493  
2.750% USD 1 250 million 2020/2050 Novartis Capital Corporation, New York, United States, issued at 97.712% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 2.75% 2.75% 2.75%    
Borrowings, original currency USD        
Notional amount $ 1,250        
Borrowings, issuance year 2020        
Borrowings, maturity year 2050        
Borrowings, issuer Novartis Capital Corporation, New York, United States        
Borrowings, issue price 97.712%        
Straight bonds $ 1,215     1,214  
0.000% 1 EUR 1 850 million 2020/2028 Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.354% [member]          
Disclosure of detailed information about borrowings [line items]          
Borrowings, coupon 0.00% 0.00% 0.00%    
Borrowings, original currency EUR        
Notional amount | €   € 1,850      
Borrowings, issuance year 2020        
Borrowings, maturity year 2028        
Borrowings, issuer Novartis Finance S.A., Luxembourg, Luxembourg        
Borrowings, issue price 99.354%        
Straight bonds $ 1,958     $ 2,076  
Borrowings interest rate step up         25.00%